Proto Labs, Inc. — Q1 2022 Form 10-Q
Reporting period: Three months ended March 31, 2022. Comparisons are with Q1 2021 unless otherwise noted. Amounts are in U.S. dollars; financial statement figures are in millions unless stated.
Business context
Proto Labs provides digitally enabled custom manufacturing, including injection molding, CNC machining, 3D printing and sheet metal fabrication. Its 2021 acquisition of Hubs added access to a network of manufacturing partners alongside its in-house operations. The company served 23,492 unique product developers and engineers in Q1, up 3.9% year over year.
Financial performance and liquidity
| Metric | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Revenue | $124.2 | $116.1 | +6.9% |
| Gross profit / gross margin | $55.8 / 44.9% | $55.3 / 47.6% | Profit +0.9%; margin down 2.7 percentage points |
| Operating expenses | $47.9 | $51.1 | −6.2% |
| Operating income / margin | $7.9 / 6.3% | $4.3 / 3.7% | Income +85.2% |
| Net income | $5.1 | $3.7 | +37.3% |
| Diluted EPS | $0.19 | $0.13 | Up $0.06 |
| Operating cash flow | $17.8 | $6.4 | Up $11.4 |
| Capital expenditures | $3.1 | $6.5 | Down $3.5 |
Cash and cash equivalents were $57.2 million at March 31, 2022, down from $65.9 million at year-end 2021. Marketable securities totaled $48.1 million, including $19.9 million current and $28.2 million long-term. Current assets were $188.2 million versus current liabilities of $60.3 million. The filing reports no borrowings; debt-like obligations shown are finance and operating lease liabilities. Total liabilities were $102.7 million and shareholders’ equity was $832.0 million.
Material changes and drivers
- Revenue growth was led by CNC Machining (+25.6%) and 3D Printing (+14.1%); Injection Molding fell 5.3% and Sheet Metal fell 10.2%.
- Revenue increased in the United States by 4.9%, Europe by 14.6% and Japan by 12.7%. Management attributed growth partly to higher average customer spend, reflecting price increases and a shift toward products with higher average order sizes. Hubs contributed revenue of $4.8 million in the U.S. and $5.5 million in Europe in Q1 2022.
- Cost of revenue rose 12.4%, faster than sales. Management cited labor shortages and wage inflation, higher raw-material and logistics costs, and Hubs-related costs. Gross margin consequently declined 2.7 percentage points.
- Operating expenses decreased 6.2%, principally because Q1 2021 included greater Protolabs 2.0 development resources, Hubs acquisition transaction costs, and stock compensation related to the former CEO’s retirement. The tax provision rose to $2.5 million from $0.2 million; the effective tax rate increased to 32.9% from 6.0%, primarily because of lower tax benefits from equity-award vesting and option exercises.
- Operating cash flow improved to $17.8 million, partly reflecting changes in operating assets and liabilities. Investing used $25.8 million, mainly for net marketable-security purchases of $22.7 million and capital spending of $3.1 million. Cash declined by $8.7 million overall.
Outlook, risks and unusual items
- No quantified revenue or earnings guidance is provided in the supplied filing text. Management expects personnel-related costs and cost of revenue to rise in absolute dollars, and anticipates continued investment in technology and personnel. It also expects future sales and marketing, R&D and G&A expenses to increase as the company grows.
- Foreign exchange reduced Q1 2022 revenue by $1.5 million year over year, primarily due to weaker pound and euro exchange rates against the U.S. dollar. The company does not hedge currency exposure; management says a hypothetical 10% adverse currency move could materially affect operating results, although it generally would not materially affect financial position.
- Interest-rate movements can affect the value of the available-for-sale securities portfolio: it had $0.6 million of unrealized losses at March 31, 2022. The filing also identifies labor and materials inflation, logistics costs, and the potential for future foreign-operation losses without tax benefits as relevant pressures.
- A Maple Plain, Minnesota facility was classified as held for sale in Q1; its carrying value was approximately $2.0 million, and management expected a sale during 2022. The filing says it had no Q1 operating-statement impact.
- The filing reports no litigation expected to have a material adverse effect, no material changes to the risks described in the 2021 Form 10-K, and no material change in internal control over financial reporting. The board’s repurchase authorization had $61.9 million remaining; there were no share repurchases in Q1.
Important facts for investors to verify
- Whether revenue growth and customer spend trends persist, particularly given declines in Injection Molding and Sheet Metal.
- Whether labor, materials and logistics inflation continues to pressure gross margin, and whether pricing or product mix offsets those costs.
- How much reported growth reflects Hubs and currency movements, and the performance and profitability of the Hubs network.
- Whether operating cash flow remains strong as receivables, inventory and other working-capital needs change.
- The eventual sale proceeds and timing for the held-for-sale facility, and the effects of unhedged currency exposure and marketable-security valuation changes.